Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network

被引:50
|
作者
Susukida, Ryoko [1 ]
Crum, Rosa M. [1 ,2 ,3 ]
Stuart, Elizabeth A. [1 ]
Ebnesajjad, Cyrus [1 ]
Mojtabai, Ramin [1 ,3 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 North Broadway Room 897, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
关键词
Clinical trials; sample representativeness; substance use disorders; MOTIVATIONAL ENHANCEMENT THERAPY; BUPRENORPHINE-NALOXONE; SOCIOECONOMIC-STATUS; SUBSTANCE-ABUSE; GENERALIZABILITY; DEPENDENCE; INCENTIVES; PREDICTORS; EDUCATION; SELECTION;
D O I
10.1111/add.13327
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To compare the characteristics of individuals participating in randomized controlled trials (RCTs) of treatments of substance use disorder (SUD) with individuals receiving treatment in usual care settings, and to provide a summary quantitative measure of differences between characteristics of these two groups of individuals using propensity score methods. Design Analyses using data from RCT samples from the National Institute of Drug Abuse Clinical Trials Network (CTN) and target populations of patients drawn from the Treatment Episodes Data Set-Admissions (TEDS-A). Settings Multiple clinical trial sites and nation-wide usual SUD treatment settings in the United States. Participants A total of 3592 individuals from 10 CTN samples and 1 602 226 individuals selected from TEDS-A between 2001 and 2009. Measurements The propensity scores for enrolling in the RCTs were computed based on the following nine observable characteristics: sex, race/ethnicity, age, education, employment status, marital status, admission to treatment through criminal justice, intravenous drug use and the number of prior treatments. Findings The proportion of those with >= 12 years of education and the proportion of those who had full-time jobs were significantly higher among RCT samples than among target populations (in seven and nine trials, respectively, at P < 0.001). The pooled difference in the mean propensity scores between the RCTs and the target population was 1.54 standard deviations and was statistically significant at P < 0.001. Conclusions In the United States, individuals recruited into randomized controlled trials of substance use disorder treatments appear to be very different from individuals receiving treatment in usual care settings. Notably, RCT participants tend to have more years of education and a greater likelihood of full-time work compared with people receiving care in usual care settings.
引用
收藏
页码:1226 / 1234
页数:9
相关论文
共 50 条
  • [1] Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network
    Susukida, Ryoko
    Crum, Rosa M.
    Ebnesajjad, Cyrus
    Stuart, Elizabeth A.
    Mojtabai, Ramin
    ADDICTION, 2017, 112 (07) : 1210 - 1219
  • [2] Increasing Ethnic Minority Participation in Substance Abuse Clinical Trials: Lessons Learned in the National Institute on Drug Abuse's Clinical Trials Network
    Burlew, Kathleen
    Larios, Sandra
    Suarez-Morales, Lourdes
    Holmes, Beverly
    Venner, Kamilla
    Chavez, Roberta
    CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOLOGY, 2011, 17 (04) : 345 - 356
  • [3] Partnerships and pathways of dissemination: The National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network
    Martino, Steve
    Brigham, Gregory S.
    Higgins, Christine
    Gallon, Steve
    Freese, Thomas E.
    Albright, Lonnetta M.
    Hulsey, Eric G.
    Krom, Laurie
    Storti, Susan A.
    Perl, Harold
    Nugent, Cathrine D.
    Pintello, Denise
    Condon, Timothy P.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) : S31 - S43
  • [4] Gender Research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A Summary of Findings
    Greenfield, Shelly F.
    Rosa, Carmen
    Putnins, Susan I.
    Green, Carla A.
    Brooks, Audrey J.
    Calsyn, Donald A.
    Cohen, Lisa R.
    Erickson, Sarah
    Gordon, Susan M.
    Haynes, Louise
    Killeen, Therese
    Miele, Gloria
    Tross, Susan
    Winhusen, Theresa
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2011, 37 (05) : 301 - 312
  • [5] Impact of Behavioral Drug Abuse Treatment on Sexual Risk Behaviors: An Integrative Data Analysis of Eight Trials Conducted Within the National Drug Abuse Treatment Clinical Trials Network
    Brown, Jennifer L.
    Eriksen, Michael D.
    Gause, Nicole K.
    Brody, Gene H.
    Sales, Jessica M.
    PREVENTION SCIENCE, 2018, 19 (06) : 761 - 771
  • [6] Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: Implications for Posttrial Implementation
    Pinto, Rogerio M.
    Campbell, Aimee N. C.
    Hien, Denise A.
    Yu, Gary
    Gorroochurn, Prakash
    AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 2011, 81 (02) : 211 - 217
  • [7] The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment
    Tai, Betty
    Straus, Michele M.
    Liu, David
    Sparenborg, Steven
    Jackson, Ron
    McCarty, Dennis
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) : S4 - S13
  • [8] The Design and Analysis of Multisite Effectiveness Trials: A Decade of Progress in the National Drug Abuse Clinical Trials Network
    Nunes, Edward V.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2011, 37 (05) : 269 - 272
  • [9] Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network
    Stitzer, Maxine L.
    Petry, Nancy M.
    Peirce, Jessica
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) : S61 - S69
  • [10] Stimulant abuser groups to engage in 12-Step: A multisite trial in the National Institute on Drug Abuse Clinical Trials Network
    Donovan, Dennis M.
    Daley, Dennis C.
    Brigham, Gregory S.
    Hodgkins, Candace C.
    Perl, Harold I.
    Garrett, Sharon B.
    Doyle, Suzanne R.
    Floyd, Anthony S.
    Knox, Patricia C.
    Botero, Christopher
    Kelly, Thomas M.
    Killeen, Therese K.
    Hayes, Carole
    Kau'iBaumhofer, Nicole
    Seamans, Cindy
    Zammarelli, Lucy
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2013, 44 (01) : 103 - 114